Abstract The NME1 gene represents the prototypical metastasis suppressor, whose expression inhibits cell motility and metastasis without impact on primary tumor growth in a number of different human cancers. This report outlines our recent efforts to define the molecular mechanisms through which NME1 both suppresses cell motility and promotes genomic integrity in the setting of human melanoma. Forced NME1 expression in a variety of melanoma-derived cell lines was shown to induce dynamic changes in cell morphology and reorganization of the actin cytoskeleton, with formation of a network of thick stress fibers and assembly of fibronectin fibrils at large focal adhesions. Moreover, NME1 expression results in adhesion reprogramming through an impact on integrin repertoire and focal adhesion dynamics. Having previously demonstrated that NME1 expression promotes repair of DNA damage induced by ultraviolet radiation (UVR) in both yeast and mammalian cells, probably via the nucleotide excision repair pathway, we have more recently demonstrated that NME1 is rapidly recruited to double-strand breaks. This preliminary result represents the first evidence of direct interactions between NME1 and DNA in the context of DNA repair and has set the stage for current efforts to probe its functional interactions with double-strand break repair pathways. Discussed herein are molecular models to explain the interactions of NME1 with such diverse cellular functions as cell motility and DNA repair, potentially through its nucleoside diphosphate kinase and 3′-5′ exonuclease activities.
Introduction
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer, and its incidence is increasing rapidly in the USA and around the world (http://seer.cancer.gov/ statfacts/html/melan.html). A particularly disturbing increase has been noted for young women exposed to UV radiation in tanning beds (Purdue et al. 2008) . Despite recent improvements in targeted therapies for management of metastatic melanoma (e.g., BRAF inhibitors and anti-CTL4), recurrence usually occurs. A better understanding of the metastatic process is acutely needed to prevent or inhibit melanoma in its advanced forms.
Metastasis suppressor genes have provided exceptional opportunities for understanding molecular events that specifically drive the metastatic cascade. The NME1 gene (aka nucleoside diphosphate kinase/NDPK, NM23-H1) represents the first prototype of a metastasis suppressor and was initially identified in the mouse melanoma cell line K-1735 as an underexpressed transcript in a metastatic variant of the line (Leone et al. 1991) . Confirmation of metastasis suppressor activity has been obtained in cell lines and tumors of melanoma, breast carcinoma, and other cancers (Hartsough and Steeg 2000) . In fact, expression of NME1 RNA has been cited as one of the most reliable prognostic indices for positive outcome in CMM (Winnepenninckx et al. 2006) . The protein exhibits three enzymatic activities that could mediate its suppressor function. First described was its NDPK activity, proposed to maintain balance in nucleotide pools by catalyzing transfer of γ-phosphate between nucleoside triphosphates (NTPs) to nucleoside 5-diphosphates (NDPs) (Agarwal et al. 1978) . A substrate channeling mechanism has been proposed in which NTPs are directly transferred from the NDPK active site to effector molecules (Crawford et al. 2006) . NME1 also exhibits a histidine kinase activity that may mediate its antimotility function (Wagner et al. 1997 ). Our laboratory described its 3′-5′ exonuclease activity (Ma et al. 2004 ) and its essentiality for metastasis suppressor function (Zhang et al. 2010) . Consistent with the known roles of these enzymes in DNA replication and repair (Shevelev and Hübscher 2002) , we demonstrated anti-mutator activity of NME1 in Saccharomyces cerevisiae (Yang et al. 2009 ) and ultraviolet radiation (UVR)-treated melanoma cells, via enhancement of the nucleotide excision repair (NER) pathway (Jarrett et al. 2011) . We recently validated metastasis suppressor activity of NME1 and the closely related NME2 gene in melanoma in vivo, using a transgenic mouse model of UV-induced melanoma (Jarrett et al. 2013) .
NME1 suppresses the motility and invasive characteristics of a number of cancer-derived cell lines (for a review, see (Salerno et al. 2003) , and our laboratory has observed this activity in multiple human melanoma lines Jarrett et al. 2011) . A prevailing view is that NME1 exerts an inhibitory influence on a number of intracellular substrates implicated in cell motility, probably involving direct proteinprotein contacts (Marino et al. 2011 ). In addition, considerable evidence indicates that NME1 exerts broad-ranging effects on the transcriptome, although the underlying mechanisms have yet to be fully elucidated. Studies have demonstrated binding of NME1 and NME2 to single-stranded motifs in the promoter regions of the CMYC (Postel et al. 1993) and PDGFA (Ma et al. 2004; Ma et al. 2005 ) genes, and these interactions and others have been validated by chromatin immunoprecipitation (Cervoni et al. 2003 (Cervoni et al. , 2006 Egistelli et al. 2009 ), suggesting NME proteins may modulate transcription of genes that affect its suppressor function. In this regard, NME1 has been shown to regulate global gene expression profiles in the breast carcinoma cell line, MDA-MB-435, with expression of the lysophosphatidic acid receptor EDG2 identified as a motility-driving target of NME1-mediated suppression (Horak et al. 2007 ). Finally, our demonstration that NME expression promotes DNA repair pathways such as NER suggests the possibility that part of its metastasis suppressor activity is mediated through inhibiting the acquisition of metastasis-driving mutations. Clearly, the cellular functions of NME proteins are myriad and its potential impacts on the metastatic process are probably complex as well. The purpose of this report is to outline recent progress made in our laboratory to define the molecular mechanisms underlying the impact of NME1 on metastasis in melanoma. In particular, we focus on its ability to (1) regulate cytoskeletal and focal adhesion dynamics and (2) promote genomic stability through direct interactions with at least two DNA repair pathways, NER and double-strand break repair (DSBR).
Motility-suppressing effects of NME1 in melanoma cells are associated with induction of thick actin stress fibers and altered focal adhesion dynamics Suppression of melanoma cell motility by NME1 is associated with profound changes in cell morphology and reorganization of the actin cytoskeleton An early observation we made upon forced expression of NME1 in aggressive melanoma cell lines (e.g., 1205Lu, M14, and WM793) was a marked alteration in cell morphology. This change was characterized by a switch from a bipolar, spindle shape with multiple filopodia in the motile parent lines to a more spread out and polygonal appearance in the NME1 transfectants. As cell morphology and migration are wellrecognized to be regulated through mechanical functions of the actin cytoskeleton (Lazaro-Dieguez et al. 2007 ), we conducted phalloidin staining for filamentous actin (F-actin) in these melanoma cell lines. The NME1-induced morphological transition was shown to be associated with generation of a network of thick F-actin bundles (stress fibers), contrasting with more finely punctate or diffuse actin staining in the parent cell line counterparts (Fig. 1 ). This is consistent with the observation that melanoma cells of low metastatic potential exhibit prominent stress fibers terminating in large focal adhesions and are associated with enhanced adhesion and reduced motility (Volk et al. 1984) . We have recently observed that fibronectin fibrils are assembled in NME1-expressing melanoma cells at large focal adhesions visualized with fluorescent paxillin. Moreover, our preliminary results suggest NME1 modestly induces expression of fibronectin mRNA and protein, which may contribute to formation of large focal adhesions. Nevertheless, localized secretion, proteolytic processing, and matrix assembly also have profound effects on the function of fibronectin, and we are currently actively investigating the effect of NME1 on these processes as well. Further complexity of the role of fibronectin in metastasis is indicated by a report that fibronectin production by fibroblasts at future organ sites of metastasis promotes recruitment of bone marrow-derived cells, which serve to prime the premetastatic niche for tumor cell colonization (Barkan et al. 2010) . Our results reinforce the notion that cell migration requires an optimal level of substrate adhesion, determined by the type and concentrations of adhesion ligands (e.g., fibronectin) in the extracellular matrix. NME1 appears to suppress motility by inducing localized deposition of fibronectin to cell-substrate adhesions at levels high enough to inhibit their turnover. Studies are underway to validate this hypothesis by using forced expression and shRNA approaches to assess the impact of endogenous fibronectin expression and matrix assembly on motility and metastatic potential of melanoma cells.
NME1 expression results in adhesion reprogramming through alterations in integrin repertoire and focal adhesion dynamics
To assess the effect of NME1 on the dynamics of focal adhesion (FA) formation and turnover, we have recently employed time-lapse video total internal reflection fluorescence (TIRF) microscopy. Visualization of FAs in metastatic melanoma cell lines with a paxillin-DsRed fusion protein has revealed rapid FA turnover at both the leading and trailing edges of cells, with new FAs appearing continuously within newly formed pseudopodia at the leading edge (Fig. 1) . In contrast, forced NME1 expression was associated with larger and more stable FAs that were somewhat enriched at opposing poles but also seen on lateral edges. The FAs migrated from the edges towards the cell interior and were continuously replaced by new FAs at all edges. The net result was a "treadmilling" of the FAs, which resulted in little or no net cell movement. Interestingly, preliminary studies indicate the effects of NME1 are not accompanied by cell-wide activation of such well-known small G protein modulators of cell motility as RhoA, Rac1, and Cdc42 nor did NME1 expression modulate the activation of these proteins in response to the chemokine SDF-1/CXCL12. This contrast with reported NME-mediated modulation of small G protein activation (for a review, see (Marino et al. 2011) ) is somewhat unexpected and indicates alternate mechanisms may be operative in melanoma. We are also addressing whether the impact of NME1 on small G protein activation may be directed to specific subcellular locations depending upon sites of integrin-ligand interactions. Localized small G protein activation, particularly in relation to the leading and trailing edges of cells, has been described (O'Connor et al. 2012) and might have been undetectable in our immunoblot analysis of whole cell extracts. One potential clue to underlying mechanisms has been provided by a microarray analysis we conducted in WM793 melanoma cells, which identified NME1-mediated downregulation of the integrin β1 (ITGB1) subunit of the α 5 β 1 fibronectin receptor. Increased ITGB1 expression has been associated with increased metastatic potential (Danen et al. 1994; Shibue and Weinberg 2009; Huck et al. 2010; Grzesiak et al. 2011 ) and shortened patient survival (Nikkola et al. 2004; Yao et al. 2007; Oshita et al. 2004 ) in melanoma and other human cancers and is receiving attention as a potential therapeutic target in metastatic disease (Barkan and Chambers 2011) . Efforts are ongoing in our laboratory to address the underlying mechanism through which NME1 regulates expression of ITGB1 and perhaps other members of the integrin family of proteins. In addition to its regulation of ITGB1 gene expression, NME1 may exert an impact on the spatiotemporal dynamics of integrin adhesion complexes at the cell surface. Of potential relevance is the equilibrium between two key fibronectin receptors, the α 5 β 1 and α v β 3 integrins, which can have profound influence on adhesion strength, FA stability, mechanosensing, matrix assembly, and, ultimately, motile and invasive behavior of tumor cells. This equilibrium has been shown to be maintained to a large extent through opposing profiles of dynamin-mediated endocytosis (Morgan et al. 2013) .
Focal adhesions with rapid turnover rates, common in actively motile cells, have been shown to be enriched for the α 5 β 1 complex. Conversely, stable FAs with slower endocytosis rates preferentially display the α v β 3 integrin complex. The conversion between slow and fast recycling beta integrin complexes is facilitated by activation of the small G protein Arf6 that in turn promotes dynamin-mediated endocytosis of FAs. The NDPK activity of NME1 has been proposed to provide GTP directly to Arf6 and dynamin to promote endocytosis (D'Souza-Schorey and Chavrier 2006; Veluthakal et al. 2013) , possibly through the direct process of "substrate channeling," as described (Crawford et al. 2006 ). More recently, a "GTP fueling" hypothesis for NME1-mediated endosomal recycling has been proposed as a metastasissuppressing mechanism in breast carcinoma via maintenance of E-cadherin expression at the cell surface. We are currently addressing the relevance of these NME1-driven mechanisms to possible switching of integrin subunits at the surface of melanoma cells (Fig. 1 ). It will also be of interest to determine whether the effects of NME1 in melanoma cells on integrin expression are cooperative with, or exclusive of, its reported interactions with intracellular modulators of cell motility and invasion (e.g., Tiam1, Dbl-1, Lbc, etc.) (Marino et al. 2011 ).
NME1 and DNA repair
Our entrance into the field of NME1 research was initiated by the identification of the protein as a DNA binding factor, revealed through the screening of a lambda phage cDNA expression library with a 5′-radiolabeled 33-mer oligodeoxynucleotide. Further study revealed NME1 exhibits a Mg +2 -dependent 3′-5′ exonuclease activity on singlestranded DNA substrates (Ma et al. 2004) . Exonucleases (3′-5′) provide DNA proofreading and trimming functions during DNA repair and replication (Shevelev and Hübscher 2002) . These are functions which are known to be required in the DSBR and translesion synthesis (TLS) pathways of DNA repair/replication, the latter in particular by virtue of its use of low fidelity DNA polymerases (e.g., DNA polymerase ζ) as part of its molecular mechanism. Our first evidence in support of a DNA repair function for NME1 was obtained in the yeast, S. cerevisiae, in which ablation of the NME1 homolog YNK1 was shown to result in delayed and error-prone repair of DNA lesions induced by ultraviolet radiation (UVR) and the DNA topoisomerase II inhibitor, etoposide (Yang et al. 2009 ). Subsequently, we demonstrated that human melanoma cell lines with coordinately low expression of NME1 and NME2 (e.g., WM793) repaired UV-induced 6-4 photoproducts and other DNA polymerase-blocking lesions at a slow rate and that the kinetics of repair were accelerated significantly upon forced expression of NME1 (Jarrett et al. 2011 ). These results were corroborated in embryo fibroblasts derived from transgenic mouse strains (MEFs) rendered null in the NME1 and/or NME2 loci, which exhibited much slower kinetics of repair of UV-induced DNA lesions than MEFs from wild-type mice. NME1 mutants deficient in NDPK activity (K 12 Q, H 118 F) exhibited impaired abilities to promote repair of UV-induced 6-4 photoproducts, while little impact was observed with a 3′-5′ exonuclease-inactivating mutation (E 5 A). This result was not surprising in light of the dominant role played by the NER pathway in 6-4 photoproduct repair. The pathway involves a DNA polymerase fill-in step after excision of a DNA segment bearing the lesion, to which the NDPK and substrate channeling activity might contribute, but which has no known requirement for a 3′-5′ exonuclease activity (Fig. 2) . Interestingly, the 3′-5′ exonuclease-dead mutant E 5 A was impaired in the ability to promote repair of DNA polymerase-blocking lesions induced by UV, as well as spontaneous and UV-induced mutations in the HPRT locus, strongly suggesting alternative repair mechanisms requiring the 3′-5′ exonuclease activity of NME1 may be operative in those settings.
More recently, to more directly address the relative contributions of the NDPK and 3′-5′ exonuclease activities of NME1 to DNA repair, we have begun to focus on the DSBR pathway, which requires both DNA polymerase and 3′-5′ exonuclease activities (Fig. 2) . One approach we are currently using is the retroviral delivery system for expression of the homing endonuclease I-PpoI as pioneered in the laboratory of Michael Kastan (Berkovich et al. 2007 ), which introduces double-strand break (DSBs) at a relatively small number of defined loci. The approach is appealing because it can be used in conjunction with chromatin immunoprecipitation to assess the recruitment of NME1 to a specific DSB repair site. Preliminary results indicate that NME1 is indeed recruited rapidly (within 30 min) to I-PpoI-catalyzed DSBs, suggesting it may be part of the initial wave of proteins (e.g., ATM) recruited as part of the DSB-sensing machinery. Consistent with this notion, we have also observed co-immunoprecipitation of NME1 and ATM following treatment with the DSB inducer bleomycin. Current efforts are being directed to fully exploiting the I-PpoI system in a variety of cancer and nontransformed cell lines to measure the kinetics and topology of NME1 recruitment to DSBs. In addition, DSBR kinetics can be determined by quantitative PCR using primers spanning known I-PpoI cleavage sites. Experiments are also underway to dissect the relative contributions of NME proteins to the two primary forms of DSBR, homologous recombination (HR) and non-homologous end-joining (NHEJ). Cell line panels such as those we have constructed in the WM793 melanoma line to express wild-type and enzymatically deficient forms of NME1 will be used to dissect the specific contributions of the NDPK and 3′-5′ exonuclease activities to these DSBR pathways.
Addressing the potential impact of the genome stabilizing activity of NME1 on cancer progression will probably prove more challenging than evaluating its effect on the motile and invasive properties of cancer cells. Nevertheless, we have already demonstrated that ablation of its 3′-5′ exonuclease activity is correlated with loss of metastasis suppressor function , at least strongly suggesting the prospect that its DNA repair function is required. We are currently applying the powerful techniques of whole genome sequencing to our NME knockout mouse model of metastatic melanoma in an effort to identify metastasis-driving mutations that may arise as a consequence of NME loss. Further analysis of the time course of their appearance and their potential interactions with known melanoma drivers would be highly informative. In fact, the possibility exists that mutations secondary to NME1 deficiency could provide evidence that NME1 loss may be initiated quite early in a subpopulation of cells within the primary tumor, perhaps playing a role in genesis or progression of a cancer stem cell compartment. . Blue arrows are directed to those processes for which the NDPK activity of NME1 may contribute nucleotides to DNA polymerases through a substrate channeling mechanism, while the red arrow represents one step in the C-NHEJ pathway at which the 3′-5′ exonuclease activity could participate
Conclusions
One implication of our studies is that NME proteins interact physically and functionally with very disparate processes in melanoma cells. On one hand, expression of NME1 has dramatic effects on morphology and motility phenotypes, at least some of which is directed to promoting strong focal adhesions via targeted secretion of fibronectin and suppressing presentation of the motility-driving integrin ITGB1 at the cell surface. The mechanisms underlying these events remain obscure at present, although we have uncovered some evidence that NME1 may regulate expression of genes that play key roles. On the other hand, NME1 clearly promotes genomic stability through interactions with at least two DNA repair pathways, NER and DSBR, and we have obtained preliminary evidence to indicate it participates directly in those processes. Moreover, NME1 clearly regulates gene expression in a host of different cellular settings, although it is not yet clear whether this is a direct effect on gene transcription and/or RNA export/stability or is secondary to signaling events initiated in the cytoplasm. An overall model summarizing the potential impacts of NME1 on cancer progression is presented in Fig. 3 . Thus, at least two major questions come to mind: how does NME1 participate in such disparate processes, and how is such a singular and profound activity as metastasis suppression executed through so many regulatory targets? While the answers are not yet within our grasp, the substrate channeling hypothesis for NDPK activity would appear to provide some commonality. For example, the NDPK activity could "fuel" both the ARF6/dynamin machinery with GTP for recycling of motility-regulating proteins at the cell surface, as well as with dNTPs for DNA polymerase function in the nucleus during DNA repair. It seems likely that much of the specificity of the overall actions of NME proteins reside in the molecular partners with which they interact. Although NME1 has been labeled a "sticky" protein (Marino et al. 2011) , careful and skilled application of biochemical and molecular biological approaches should provide insights needed for the eventual decoding of its biological functions and roles in cancer progression. 
